ELOXX PHARMACEUTICALS, INC.
Last · NASDAQ$12.21-0.49 (-3.86%)close · yahoo · 15h ago
Vol 12.5K ≈ 152.6K
MA10MA20MA50
Market cap$49.29M4.0M sh
P/E · TTM3.5fwd -17.2 · eps 3.46
Beta-171332.88vs S&P 500
Div yield0.00%annual · TTM
52w range
$8.20$23.40
Volume12.5Ksession
Issuer
Legal nameELOXX PHARMACEUTICALS, INC.
HQUnited States (US)
ListingUS ELOX
ISINUS29014R3012
SectorHealthcare
IndustryDrugs (Biotechnology)
SIC2836
CurrencyUSD
Entity registrysec:0001035354
CIK0001035354
Websitewww.eloxxpharma.com
Employees10
AddressEloxx Pharmaceuticals, Inc. 10 Court Street 02476, Arlington
Loading chart…
OpenFilings analyst
Our analyst
10-K · 2026-03-17
From latest 10-K · 2026-03-17
- Operating Cf Burn
- Net Margin Sharply Negative
- Cash Runway Low
- Current Ratio Low
Red flags
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -49.4%
- Cash Runway Low — Cash runway ~0.8 years
- Current Ratio Low — Current ratio 0.31
Documents
FormReporting forFiledFlags
Showing 5 of 35 filings